cells ecs differentiation (Lonza)
Structured Review

Cells Ecs Differentiation, supplied by Lonza, used in various techniques. Bioz Stars score: 97/100, based on 339 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cells ecs differentiation/product/Lonza
Average 97 stars, based on 339 article reviews
Images
1) Product Images from "Cardiac Progenitors Induced from Human Induced Pluripotent Stem Cells with Cardiogenic Small Molecule Effectively Regenerate Infarcted Hearts and Attenuate Fibrosis"
Article Title: Cardiac Progenitors Induced from Human Induced Pluripotent Stem Cells with Cardiogenic Small Molecule Effectively Regenerate Infarcted Hearts and Attenuate Fibrosis
Journal: Shock (Augusta, Ga.)
doi: 10.1097/SHK.0000000000001133
Figure Legend Snippet: According to treatment outline, the CPCs expressed CM, EC, SMC specific proteins. (A) CM progenitors expressed α-sarcomeric actinin, cTnI, MLC2v, cTnT and Cx43, scale bar = 50 μm. (B) Under TEM, these cells were rich in endoplasmic reticulum (ER) studded with ribosomes, developing myofilaments (mf), mitochondria (arrowhead) and glycogen particles. Nuclear chromatin material (N) was uniformly distributed in the nucleoplasm. (C) Endothelial progenitors expressed VE-cadherin and CD31, scale bar = 200 μm. LDL uptake by these cells was observed (D) and these also formed tube like structures (E). (F) Smooth muscle progenitors expressed a-SMA and calponin, scale bar = 200 μm. (G) FACS analysis revealed 95.2 ± 2.1% CMS, 90.3 ± 2.5% ECs and 92.3 ± 1.8% SMCs in basal differentiation medium.
Techniques Used: